have evolved
Harnessing more of the immune system for better cancer outcomes
Latest News

Excited to join @oNKo_innate in Jan 2022 & have the opportunity to contribute to their important, cutting-edge #cancerImmunotherapy discoveries! Great to still work with the same amazing & brilliant scientists I have been learning so much from @JoeCursons @Dr_Nick_Bikes

Load More...
Discover oNKo-innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
Learn more
Using powerful genomic approaches, we screen primary immune cells and cancer cells to understand their interaction within a tumor.
Learn more
o o
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
Find out who we are